Further improvements in the technology of HSV-1-based amplicon vectors

Author： Cuchet Delphine   Epstein Alberto L  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.18, Iss.7, 2008-07, pp. : 797-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HSV-1 Based Amplicon Vectors as an Alternative System for the Expression of Functional HCV Proteins

By  

Current Gene Therapy, Vol. 6, Iss. 3, 2006-06 ,pp. : 393-398

Bentham Science Publishers

Access to resources Recommend Favorite

HSV-1-Derived Recombinant and Amplicon Vectors for Gene Transfer and Gene Therapy

By  

Current Gene Therapy, Vol. 5, Iss. 5, 2005-10 ,pp. : 445-457

Bentham Science Publishers

Access to resources Recommend Favorite

HSV Amplicon Vectors for Cancer Therapy

By  

Current Gene Therapy, Vol. 6, Iss. 3, 2006-06 ,pp. : 361-370

Bentham Science Publishers

Access to resources Recommend Favorite

HSV-1 Amplicon Vectors Are an Efficient Gene Transfer System for Skeletal Muscle Cells

By  

Current Gene Therapy, Vol. 6, Iss. 3, 2006-06 ,pp. : 371-381

Bentham Science Publishers

Access to resources Recommend Favorite

The History of the HSV Amplicon: From Naturally Occurring Defective Genomes to Engineered Amplicon Vectors

By  

Current Gene Therapy, Vol. 6, Iss. 3, 2006-06 ,pp. : 277-299

Bentham Science Publishers

Access to resources Recommend Favorite